Proceedings of the National Academy of Sciences · 1998 · 332 citations · 26 references
Life SciencesMicrobiologyMolecular BiologyCell SignalingMicrobial PathogenesisMolecular Cell BiologyCystic FibrosisInnate Immune ResponseInnate Immune Signaling PathwaysMucociliary ClearanceMucosal PathogenesisChronic Pseudomonas Aeruginosa InfectionEpithelial Cell InteractionsEpithelial-microbe InteractionsGenetic Disease MechanismsMolecular Mechanisms Of PathogenesisMucin GlycoproteinsNf-κb SignalingNuclear Factor Kappa B Signaling
Cystic fibrosis (CF) is an autosomal recessive disorder, the most common lethal genetic disease in Caucasians. Respiratory disease is the major cause of morbidity and mortality. Indeed, 95% of CF patients die of respiratory failure. Pseudomonas aeruginosa, an opportunistic pathogen, chronically infects the lungs of over 85% of CF patients. It is ineradicable by antibiotics and responsible for airway mucus overproduction that contributes to airway obstruction and death. The molecular mechanisms underlying this pathology are unknown. Here we show that P. aeruginosa activates a c-Src-Ras-MEK1/2-MAPK-pp90rsk signaling pathway that leads to activation of nuclear factor NF-kappaB (p65/p50). Activated NF-kappaB binds to a kappaB site in the 5'-flanking region of the MUC2 gene and activates MUC2 mucin transcription. These studies bring new insight into bacterial-epithelial interactions and more specifically into the molecular pathogenesis of cystic fibrosis. Understanding these signaling and gene regulatory mechanisms opens up new therapeutic targets for cystic fibrosis.
26
Patrick A. Baeuerle, David Baltimore · Cell · 1996 · 3K citations · Full text
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
Joseph A. DiDonato, Makio Hayakawa, David M. Rothwarf et al. · Nature · 1997 · 2.1K citations